Header Logo

Nicholas Moore

TitleAssociate Professor
InstitutionRush University, College of Health Sciences
DepartmentMedical Laboratory Science
Address
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    My Scopus ID is 37085372100.

    My ORCID ID is 0000-0002-9734-8905.

    My NIH COMMONS name is NMOORE2.

    My academic profile: https://www.rushu.rush.edu/faculty/nicholas-moore-ms-mlsascpcm

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Narayanan N, Mathers AJ, Wenzler E, Moore NM, Giske CG, Mendes RE, Edelstein PH. Amoxicillin-Clavulanate Breakpoints Against Haemophilus influenzae: Rationale for Revision by the Clinical and Laboratory Standards Institute2. Clin Infect Dis. 2025 Feb 24; 80(2):481-482. PMID: 38709848; PMCID: PMC11848255.
      Citations:    
    2. Sundermann AJ, Rosa R, Harris PNA, Snitkin E, Javaid W, Moore NM, Hayden MK, Allen K, Rodino K, Peacock SJ, Abbo LM, Harrison LH. Pathogen genomics in healthcare: overcoming barriers to proactive surveillance. Antimicrob Agents Chemother. 2025 Jan 31; 69(1):e0147924. PMID: 39636107; PMCID: PMC11784250.
      Citations:    
    3. Sansom SE, Shimasaki T, Dangana T, Lin MY, Schoeny ME, Fukuda C, Moore NM, Yelin RD, Bassis CM, Rhee Y, Cisneros EC, Bell P, Lolans K, Aboushaala K, Young VB, Hayden MK. Comparison of Daily Versus Admission and Discharge Surveillance Cultures for Multidrug-Resistant Organism Detection in an Intensive Care Unit. J Infect Dis. 2024 Oct 16; 230(4):807-815. PMID: 38546721.
      Citations:    
    4. Narayanan N, Mathers AJ, Wenzler E, Moore NM, Giske CG, Mendes RE, Edelstein PH. Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute. Clin Infect Dis. 2024 08 16; 79(2):516-523. PMID: 38626241; PMCID: PMC11327796.
      Citations:    
    5. Miles-Jay A, Snitkin ES, Lin MY, Shimasaki T, Schoeny M, Fukuda C, Dangana T, Moore N, Sansom SE, Yelin RD, Bell P, Rao K, Keidan M, Standke A, Bassis C, Hayden MK, Young VB, Miles-Jay A, Snitkin ES, Lin MY, Shimasaki T, Schoeny M, Fukuda C, Dangana T, Moore N, Sansom SE, Yelin RD, Bell P, Rao K, Keidan M, Standke A, Bassis C, Hayden MK, Young VB. Longitudinal genomic surveillance of carriage and transmission of Clostridioides difficile in an intensive care unit. Nat Med. 2023 10; 29(10):2526-2534. PMID: 37723252; PMCID: PMC10579090.
      Citations:    
    6. Abraham A, Moore N, Sansom SE. When dyspnea is a Hickam's Dictum. IDCases. 2023; 32:e01786. PMID: 37207173; PMCID: PMC10189454.
      Citations:    
    7. Furlan K, Rohra P, Mir F, Sethi S, Almajnooni A, Gattuso P, Moore N, Furlan K, Rohra P, Mir F, Sethi S, Almajnooni A, Gattuso P, Moore N. Mycobacterium Spindle Cell Pseudotumor Caused by Mycobacterium xenopi: A First Described Association of a Rare Entity Presenting in the Lung. Int J Surg Pathol. 2020 May; 28(3):316-320. PMID: 31601138.
      Citations:    
    8. Lin MY, Lolans K, Blom DW, Lyles RD, Weiner S, Poluru KB, Moore N, Hines DW, Weinstein RA, Hayden MK, Lin MY, Lolans K, Blom DW, Lyles RD, Weiner S, Poluru KB, Moore N, Hines DW, Weinstein RA, Hayden MK, Centers for Disease Control and Prevention Epicenter Program. The effectiveness of routine daily chlorhexidine gluconate bathing in reducing Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae skin burden among long-term acute care hospital patients. Infect Control Hosp Epidemiol. 2014 Apr; 35(4):440-2. PMID: 24602954; PMCID: PMC8381087.
      Citations:    
    Moore's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (39)
    Explore
    _
    Co-Authors (7)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _